 Omeros Corporation NASDAQ: OMER has agreed to sell Omidria to Rayner Surgical Group Limited for an upfront payment of 125 million with an additional 200 million in commercial milestones. Omidria phenylephrine and ketorolac intraocular solution 1 0.3 is approved for use during cataract surgery or intraocular lens replacement to maintain pupil size and reduce postoperative ocular pain. 